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DNA polymerase c( was purified from human KB cells by immunoaffinity chromatography. Enzyme activity 
was inhibited by three different monoclonal antibodies (SJK-132, SJK-211, SJK-287). Kinetic analysis 
showed that each antibody neutralized polymerase activity by a different mechanism. SJK- 132 was competi- 
tive with DNA indicating it interacts with the DNA binding domain of the polymerase. SJK-287 showed 
a biphasic response to dCTP suggesting two dCTP binding sites exist on polymerase LX SJK-211 was non- 
competitive with DNA, dCTP and dATP. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
The availability of monoclonal antibodies to 
DNA polymerase a [l] has permitted detailed 
analysis of the properties and distribution of this 
enzyme. These antibodies have been used to 
localize DNA polymerase cy to the cell nucleus [2] 
and assisted in defining the separation of the 
polymerase LY and DNA primase active sites [3,4]. 
Furthermore, a rapid immunoaffinity purification 
of this enzyme was developed by employing the 
monoclonal antibodies [3]. 
2.1. Assay of DNA polymerase LY 
The standard assay has been described in detail 
[6]. Kinetic analyses were performed using these 
assay conditions with variables indicated in the 
figures. Prior to initiating the reaction, enzyme 
was added to a mixture of antibody and substrate, 
and incubated for 10 min. Activated salmon sperm 
DNA served as template/primer in these ex- 
periments after extraction with phenol and dialysis 
into 10 mM Tris-HCl, pH 8.1, 1 mM EDTA. 
Inhibition kinetics have proven to be a powerful 
tool in elucidating the reaction mechanism of DNA 
polymerase (Y [5]. The coupling of this information 
with details of the structural organization of this 
enzyme may eventually lead to a comprehensive 
understanding of how polymerase a functions. 
2.2. DNA polymerase cy immunopurification 
In this communication the use of MgC12 to im- 
munopurify KB cell DNA polymerase cy is 
presented and the application of neutralizing 
monoclonal antibodies as kinetic probes of 
polymerase LY is described. 
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Polymerase cy was extracted from human KB 
cells (9 1, 3.5 x lo5 cells/ml) and purified by 
phosphocellulose chromatography [3]. The 
phosphocellulose pool was rotated 12 h at 4°C 
with SJK-237 antibody [l] covalently coupled to 
Sepharose 4B (Pharmacia). The resin (1.5 ml) was 
pelleted by centrifugation, washed twice with 
20 ml phosphate-buffered saline (PBS), trans- 
ferred to a column and washed with another 20 ml 
PBS. The resin was then washed with 20 ml solu- 
tion A (50 mM Tris-HCI, pH 8.1, 1 mM 
2-mercaptoethanol) containing 1.0 M NaCl and 
eluted with 2.0 M MgClz in solution A. Fractions 
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(1 .O ml) were assayed, pooled and desalted by 
Sephadex G-50 (Pharmacia) chromatography into 
solution B (solution A containing 20 mM NaCl, 
20% ethylene glycol). The Sephadex G-50 pool was 
concentrated by dialysis against 30% sucrose, 
0.05% Triton X-100 in solution B. 
3. RESULTS AND DISCUSSION 
3.1. Purification of DNA polymerase cy 
The availability of monoclonal antibodies to 
DNA polymerase a has made it possible to prepare 
highly purified enzyme. Immunoaffinity purifica- 
tion of polymerase (Y from mouse, human and 
bovine tissues has been described [3,7-g]. To over- 
come the difficulty of dissociating the polymerase 
from the antibody, DNA polymerase LY from KB 
cells was purified in conjunction with the antibody 
[3]. Although there was no apparent influence of 
the antibody on the catalytic properties of the en- 
zyme [lo], it was unsuitable for studying the ef- 
fects of antibody binding. 
To obtain KB cell polymerase CY without an 
associated antibody molecule, a procedure 
developed for the purification of calf thymus 
polymerase was used [7]. KB cell polymerase a was 
bound to antibody covalently linked to Sepharose 
and eluted with 2.0 M MgClz. Lower concentra- 
tions of MgClz did not efficiently elute polymerase 
LY while higher concentrations irreversibly inhibited 
activity. Analysis of the protein components of 
DNA polymerase CY by SDS-polyacrylamide gel 
electrophoresis (fig.1) showed that the core 
polymerase polypeptides of 180, 165, 140 and 
77 kDa were the major species present. The levels 
of 55 and 49 kDa proteins, usually considered part 
of the polymerase LY complex [3], were greatly 
reduced. This polypeptide pattern resembled the 
subunit structure of calf thymus polymerase LY [7] 
indicating a comparable efficiency of purification. 
Although the overall yield of polymerase obtained 
with this procedure was lower than the yield ob- 
tained from the protocol originally developed for 
the KB enzyme (25%), no immunoglobin subunits 
(52 and 23 kDa) were evident, thus ensuring this 
enzyme preparation was suitable for the kinetic ex- 
periments performed. 
3.2. Kinetic characterization of antibody 
inhibition 
Fig. 1. Subunit composition of immunoaffinity purified 
DNA polymerase (Y. Enzyme was precipitated with 10% 
trichloroacetic acid, subjected to SDS-gel electro- 
phoresis in 8% polyacrylamide 1211 and protein 
visualized by silver staining [22]. 
Monoclonal antibodies are among the most 
specific binding molecules known [l l] and this 
specificity, when combined with neutralizing 
capabilities, makes them excellent reagents for 
kinetic studies. However, both the high dissocia- 
tion constant of the antibody-antigen complex and 
the size of the immunoglobin protein pose dif- 
ficulties for their use in kinetic analysis. Polyclonal 
sera may inhibit enzyme activity through a specific 
interaction with the enzyme or by steric hindrance. 
Affinity purification of an antibody from sera 
greatly reduces inhibition caused by steric hin- 
drance [12]. Monoclonal antibodies are highly 
purified so it can be assumed that their neutralizing 
ability is due to a specific interaction with DNA 
polymerase. Although several kinetic studies of an- 
tibody inhibition have been described using 
Michaelis-Menten graphics [ 12,131, they are 
generally unsuited to studying tight-binding reac- 
tions. Equations derived for interactions involving 
high dissociation constants are available and have 
been applied to antibody inhibition [14]. 
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The inhibition of DNA polymerase cy by the 
monoclonal antibodies SJK-132, SJK-211 and 
UK-287 [l] may result from an interaction at one 
of the substrate binding sites. The tight-binding 
equations of Henderson fl5] were used to examine 
the relationship of antibody inhibition and DNA. 
The data are summarized in fig.2. In the primary 
plot, a set of straight lines was obtained with 
SJK-132 antibody which increased in slope as 
higher DNA concentrations were added (fig.2). A 
secondary plot of slope versus DNA concentration 
(fig.2, inset) gave a straight line with a slope >0 
which is typical of competitive inhibition [15]. A Ki 
of 0.06 ag was calculated from the y-intercept of 
the secondary plot (fig.2, inset). A similar study 
with SJK-211 showed that this antibody was non- 
competitive with DNA (fig.2, inset). Data obtained 
with SJK-287 were inconclusive since curved lines 
were obtained in the primary plot (not shown). 
In addition to binding DNA, polymerase LY has 
a binding site for deox~ucleotide 5 ’ -triphos- 
phates. Kinetic experiments designed to determine 
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Fig.2. Graphical representation of kinetic data obtained 
by inhibition of DNA polymerase ry by monoclonal 
antibodies under conditions of varied DNA con- 
centration. Primary plot of data given by SJK-132. Each 
data point represents the average of duplicate assays and 
lines were determined by least squares analysis, Symbols 
are for 0.08 mM (o), 0.32 mM (0), 0.96 mM (m) and 
1.6 mM (0) DNA. (Inset) Secondary plot of data 
presented for SJK-132 (A) including data for SJK-211 
(A). 
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Fig.3. Secondary plot of kinetic data obtained with 
varied dCTP concentrations. Evaluation of the data was 
performed as described in fig.2. Results for SJK-132 
(o), SJK-211 (0) and SJK-287 (A) are shown. 
the effects of the antibodies on the interaction of 
polymerase (Y with dATP showed they were all 
non~om~titive (not shown). The secondary plot 
of a similar study with dCTP is shown in fig.3. 
Both SJK-132 and SJK-211 were non-competitive 
with dCTP, producing lines with a slope = 0. In 
contrast, SJK-287 gave a curved line representing 
a series of lines in the primary plot with decreasing 
slope at higher dCTP concentration. This pattern 
is consistent with uncompetitive inhibition [ 151. 
This indicated that there is an interaction of the an- 
tibody with a polymerase-dCTP complex. 
Although this conclusion is clear from fig.3, the 
primary plot (not shown) showed a break in the 
lines at it/(1 - V~/YO) = 0.3. At this point the slope 
of each line became 1.2, thus indicating non- 
competitive inhibition. The biphasic nature of the 
SJK-287 kinetics possibly reflects two separate 
events related to dCTP binding. These events may 
involve, among other possibilities, two dCTP 
binding sites on a single enzyme or different af- 
finities of dCTP for the various forms of the 
catalytic subunit (~180, ~165, ~140). Structural 
analysis of both KB and calf thymus DNA 
polymerase has proven that the high molecular 
mass subunits show extensive homology and are 
probabfy derived from a common precursor 
[lo, 161. Since SJK-287 interacts to the same extent 
with ~180, ~165 and ~140 [lOI it is unlikely that 
sufficient differences exist between these polypep- 
tides to alter their interaction with dCTP. Indica- 
tions that two dCTP binding sites are present on 
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polymerase cy, however, have been made. There is 
evidence for the presence of an allosteric site which 
binds dCTP [17] and it has been suggested that the 
enzyme is composed of two catalytic subunits 
[7,10]. Further investigations are necessary to 
clarify the nature of this observation since insuffi- 
cient information is available to interpret these 
data. 
Previous studies have shown the presence of two 
binding domains on DNA polymerase a! for DNA, 
one for the template and another for the primer 
terminus [5,18]. Interaction of polymerase ar with 
DNA occurs in two stages [5], binding of the 
template and subsequent binding of primer ter- 
minus. The small amounts of available protein 
made testing for inhibition of DNA binding unsuc- 
cessful by filter binding [19] or gel electrophoresis 
[20] so that the effect of SJK-132 antibody on 
template binding could not be determined. It must 
be noted, however, that an analogous situation ex- 
ists for poly(ADP-ribose) synthetase where the in- 
hibitor of a specific interaction between the 
synthetase and DNA was competitive with DNA 
yet DNA binding was unaffected [19] and in- 
hibitors of DNA binding were non-competitive 
(Zahradka and Ebisuzaki, unpublished). 
In this report a procedure for the immunoaffini- 
ty purification of KB DNA polymerase a is 
presented which circumvents the use of less 
purified enzyme fractions for i~unokinetic 
studies. The results obtained with this enzyme 
preparation show that the neutralizing antibodies 
developed against DNA polymerase (Y interact with 
unique substrate binding domains present on the 
enzyme. These data further indicate that each an- 
tibody inhibits enzyme activity by affecting a dif- 
ferent catalytic process of the pol~erization 
reaction. 
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